Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,678,625
-
Share change
-
-1,049,166
-
Total reported value
-
$38,187,488
-
Put/Call ratio
-
100%
-
Price per share
-
$2.60
-
Number of holders
-
71
-
Value change
-
-$2,781,197
-
Number of buys
-
37
-
Number of sells
-
20
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q4 2016
As of 31 Dec 2016 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,678,625 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, Palo Alto Investors, LLC, BlackRock Institutional Trust Company, N.A., GRANAHAN INVESTMENT MANAGEMENT INC/MA, STATE STREET CORP, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT INC, and WealthTrust Axiom LLC.
This table shows 71 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.